The next two decades of mifepristone at FDA: History as destiny

Autor:	Eli Y. Adashi, Rohit S. Rajan, Daniel P. O'Mahony, I. Glenn Cohen
Rok vydání:	2021
Předmět:	Mifepristone Reproductive Medicine Pregnancy United States Food and Drug Administration Obstetrics and Gynecology Humans Abortion Induced Female United States
Zdroj:	Contraception. 109
ISSN:	1879-0518
Popis:	Congressional and presidential records reveal a consistent pattern of political intercession with the regulatory authority of the Food and Drug Administration (FDA) over the approval and labeling of mifepristone (RU-486). This pattern is unlikely to abate any time soon. It is against this backdrop that we examine herein the ongoing legislative and legal disputes over mifepristone at a point in time which is just beyond the 20th anniversary of its approval by the FDA "for the medical termination of intrauterine pregnancy."
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9841fa2c27f0e98a86398ecdd7b130d1 https://pubmed.ncbi.nlm.nih.gov/35131290 Zobrazit plný text záznamu Full Text from ScienceDirect